ALFA Finder| EBITDA Margin: guided vs achieved | 24.20% achieved Guided 22.00%–23.00%, 5.2% above the top of the range; confirmed by management |
|---|---|
| EBITDA Margin guidance | 22.5% → 23.0% Raised by 0.5 percentage points |
| Revenue growth | 51% YoY revenue growth reached INR 534 crores. |
|---|---|
| Margins | Structural expansion to 24.2% via tactical specialty focus. |
| Demand visibility | Strong visibility cited for coming quarters, especially in US specialty. |
| Management confidence | Balanced and optimistic regarding specialty pipeline and facility integrations. |
Growth
Strong 51% YoY revenue growth driven by specialty portfolio; EBITDA margins expanded to 24.2% despite geopolitical cost headwinds.
Outlook
EBITDA margin guidance raised to 23% for FY27; Pithampur and US facility commercialization expected by Q4FY27.
Risks
Geopolitical impact on freight/input costs and higher ESOP/pre-revenue costs at new US and Pithampur facilities.
Last quarter's promises, checked
Delivered
- EBITDA Margin 22-23% → delivered 24.2% (= BEAT)
- R&D Productivity ~5.0x → delivered 5.5x (= BEAT)
- Top 5 Concentration ~39% → delivered 36% (= BEAT)
Partly delivered
- Pithampur Inspection Q1CY27 → Site inspected, awaiting final clearance (= PARTIAL)
Earnings Call Transcript filed with NSE, NSE: RUBICON. Summary written with AI assistance from the document.
Rubicon Research Ltd: key numbers
- Share price
- ₹1,734.00
- Market cap
- ₹28,703 Cr
- Revenue (annual)
- ₹1,754 Cr
- Net profit (annual)
- ₹246.7 Cr
- P/E (TTM)
- 88.4×Sector 43.8×
- Promoter holding
- 51.25%-8.51% QoQ
- FII holding
- 9.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Rubicon Research Ltd
All →Rubicon Research Earnings Call Transcript: Key Takeaways
Q2 revenue rose 40% to ₹576 Cr with 25% operating EBITDA margin and ₹90 Cr PAT. Arena acquisition flatters growth, and recent plant inspections remain unresolved.
Rubicon Research Other Announcement
Rubicon Research filed the India Ratings monitoring agency report for the IPO fresh issue proceeds for the quarter ended September 30, 2026. The agency found no deviation from the stated objects of the issue.
Rubicon Research Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹5,764Mn (+39.9%), EBITDA ₹1,464Mn (+54.1%, 25.4% margin), PAT ₹904Mn (+67.9%). Arinna consolidated; FY27 margin guidance raised to 24%+.
Rubicon Research Q2 FY27 Results: Net Profit ₹90.4 Cr, Up 67.7% YoY
Rubicon Research Ltd reported revenue from operations of ₹576.4 Cr (+39.9% YoY) and net profit of ₹90.4 Cr (+67.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹90.4 Cr · +67.7% YoY
Rubicon Research Employee Stock Options
Rubicon Research Limited granted 68,982 stock options at an exercise price of Rs. 1,374.40 per share. The options vest over five years under the company's 2026 ESOP plan.
Rubicon Research Business Update
Rubicon Research disclosed a USFDA inspection of its Ambernath facility, which issued five procedural Form 483 observations. No monetary penalty or amount is involved.